Featured Research

from universities, journals, and other organizations

Chimpanzee Virus May Be Key To Better Vaccines, Study Shows

Date:
March 6, 2002
Source:
Wistar Institute
Summary:
Immunologists know that human adenoviruses, a common cause of respiratory-tract infections in people, can be retooled in the laboratory to serve as effective vaccines against an array of viral diseases. When genetically engineered to express selected genes from other viruses - such as rabies, HIV, smallpox - adenoviruses infect human cells without doing them lasting damage and stimulate a vigorous, long-lasting immune response when they do so.

PHILADELPHIA - Immunologists know that human adenoviruses, a common cause of respiratory-tract infections in people, can be retooled in the laboratory to serve as effective vaccines against an array of viral diseases. When genetically engineered to express selected genes from other viruses - such as rabies, HIV, smallpox - adenoviruses infect human cells without doing them lasting damage and stimulate a vigorous, long-lasting immune response when they do so.

Related Articles


That's the theory, anyway. But there are significant problems with the theory. Adenoviruses are nearly ubiquitous among humans, so much so that a third or more of the population have neutralizing antibodies circulating in the blood able to inactivate an adenoviral-based vaccine.

Now, in a new proof-of-principle study in mice, researchers at The Wistar Institute and the University of Pennsylvania have shown that a vaccine based on a chimpanzee adenovirus possesses the immunological strengths of a human adenovirus vaccine without its drawbacks. The study appears in the March issue of the Journal of Virology.

"The chimpanzee adenovirus vaccine works like a charm," says Hildegund C.J. Ertl, M.D., a professor at The Wistar Institute and senior author on the study. "It's immunologically potent, and it's clear from our study that it would not be inactivated due to viral pre-exposure, as vaccines based on human adenoviruses can be."

For the study, the scientists developed two prototype vaccines against the rabies virus. One was a human adenovirus that incorporated one rabies gene, and the other was a chimpanzee adenovirus with the same gene. In mice unexposed to either type of adenovirus, the vaccines both elicited strong antibody responses. In mice pre-exposed to the human adenovirus, however, the vaccine based on the human adenovirus was severely compromised, while the one based on the chimpanzee adenovirus maintained its effectiveness.

Ertl and her coworkers are now working on similar prototype vaccines against HIV, smallpox, and other viruses.

"There are any number of viral diseases against which this approach would be effective, including many of the potential bioterror viruses," says Ertl.

A number of human adenovirus vaccines are currently under development against HIV and are considered by many to be among the most promising vaccine candidates in the field, despite the issue of viral pre-exposure.

Ertl emphasizes the inherent safety of the chimpanzee adenovirus vaccine concept she and her colleagues have developed. Concerns that a contaminant might accompany the vaccine - a virus like HIV, for example, which originated in chimpanzees - are addressed by the laboratory procedures by which the vaccine is generated.

Using techniques developed under the guidance of collaborator James M. Wilson, M.D., Ph.D., director of the Institute for Human Gene Therapy of the University of Pennsylvania, the vaccine is constructed, molecule by molecule, from the genetic code for the viral carrier - the chimpanzee adenovirus, in this case - and for the gene or genes to be incorporated, such as the rabies gene in the current study. The genes that coordinate replication of the virus are deleted. Any possible contaminant - another virus, a bacterium, even a prion - is eliminated in this process.

"Because of the laboratory methods used to generate this vaccine, there is no danger of giving people an unknown virus or other entity from the chimpanzee," says Ertl.

###In addition to senior author Ertl and collaborating coauthor Wilson, the lead author on the Journal of Virology study is Zhiquan Xiang, M.D., a member of Ertl's laboratory. Arturo Reyes-Sandoval , also in Ertl's laboratory, is a coauthor. Sandoval is also affiliated with the Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, Mexico City, Mexico. The remaining coauthors are Guangping Gao and Yan Li of the University of Pennsylvania and Christopher J. Cohen and Jeffrey M. Bergelson of the Children's Hospital of Philadelphia.

Funding for the research was provided by the National Institutes of Health and Genovo. James M. Wilson owns equity in Targeted Genetics, formerly Genovo.


Story Source:

The above story is based on materials provided by Wistar Institute. Note: Materials may be edited for content and length.


Cite This Page:

Wistar Institute. "Chimpanzee Virus May Be Key To Better Vaccines, Study Shows." ScienceDaily. ScienceDaily, 6 March 2002. <www.sciencedaily.com/releases/2002/03/020306072948.htm>.
Wistar Institute. (2002, March 6). Chimpanzee Virus May Be Key To Better Vaccines, Study Shows. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2002/03/020306072948.htm
Wistar Institute. "Chimpanzee Virus May Be Key To Better Vaccines, Study Shows." ScienceDaily. www.sciencedaily.com/releases/2002/03/020306072948.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins